BioMarin Pharmaceutical (BMRN) Tops Q1 Earnings Estimates

BioMarin Pharmaceutical (BMRN) came out with quarterly earnings of $0.71 per share, beating the Zacks Consensus Estimate of$ 0.60 per share. This compares to earnings of $0.60 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 18.33%. A quarter ago, it was expected that this rare disease biopharmaceutical would post earnings of$ 0.44 per share when it actually produced earnings of $0.49, delivering a surprise of 11.36%.Over the l ...